Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

May Daher

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Seminars in Hematology|December 1, 2020
The evolution of NK cell immunotherapy for hematologic malignancies: A historical and contemporary perspectiveMay Daher, Katayoun Rezvani
Cell|August 8, 2025
iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosisMay Daher, Katayoun Rezvani
Current Opinion in Immunology|April 2, 2018
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineeringMay Daher, Katayoun Rezvani
Biochemistry|April 10, 2012
Fluorescence characterization of the transfer RNA-like domain of transfer messenger RNA in complex with small binding protein BMay Daher, David Rueda
Cancer Discovery|December 5, 2020
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against CancerMay Daher, Katayoun Rezvani
Nature Cancer|March 25, 2025
Exploiting HLA-DR mismatches for CAR therapy in acute myeloid leukemiaMay Daher, Katayoun Rezvani
Hematology. American Society of Hematology. Education Program|December 4, 2020
Next-generation cell therapies: the emerging role of CAR-NK cellsRafet Basar, May Daher, Katayoun Rezvani
Blood Advances|November 24, 2020
Next-generation cell therapies: the emerging role of CAR-NK cellsRafet Basar, May Daher, Katayoun Rezvani
British Journal of Haematology|November 20, 2020
Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunityHind Rafei, May Daher, Katayoun Rezvani
Frontiers in Immunology|December 9, 2022
Multiplexed engineering and precision gene editing in cellular immunotherapyAlexander Biederstädt, Gohar Shahwar Manzar, May Daher
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Seminars in Hematology|December 1, 2020
The evolution of NK cell immunotherapy for hematologic malignancies: A historical and contemporary perspectiveMay Daher, Katayoun Rezvani
Cell|August 8, 2025
iPSC-derived CAR-NK cells: Off-the-shelf cellular therapy for systemic sclerosisMay Daher, Katayoun Rezvani
Current Opinion in Immunology|April 2, 2018
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineeringMay Daher, Katayoun Rezvani
Biochemistry|April 10, 2012
Fluorescence characterization of the transfer RNA-like domain of transfer messenger RNA in complex with small binding protein BMay Daher, David Rueda
Cancer Discovery|December 5, 2020
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against CancerMay Daher, Katayoun Rezvani
Nature Cancer|March 25, 2025
Exploiting HLA-DR mismatches for CAR therapy in acute myeloid leukemiaMay Daher, Katayoun Rezvani
Hematology. American Society of Hematology. Education Program|December 4, 2020
Next-generation cell therapies: the emerging role of CAR-NK cellsRafet Basar, May Daher, Katayoun Rezvani
Blood Advances|November 24, 2020
Next-generation cell therapies: the emerging role of CAR-NK cellsRafet Basar, May Daher, Katayoun Rezvani
British Journal of Haematology|November 20, 2020
Chimeric antigen receptor (CAR) natural killer (NK)-cell therapy: leveraging the power of innate immunityHind Rafei, May Daher, Katayoun Rezvani
Frontiers in Immunology|December 9, 2022
Multiplexed engineering and precision gene editing in cellular immunotherapyAlexander Biederstädt, Gohar Shahwar Manzar, May Daher
Pageof 9